Saturday, June 14, 2025
  • Advertise
  • Recruitment
  • Contact us:
  • Register
Irish Pharmacy News
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
Irish Pharmacy News
Home Developments

Blood clots related to AstraZeneca/Oxford vaccine can be mitigated with early detection

Robyn Maginnis by Robyn Maginnis
29 June 2021
in Developments
0
Blood clots related to AstraZeneca/Oxford vaccine can be mitigated with early detection

New research highlights the need for heightened awareness and early testing for patients with signs of clotting disorder following vaccination

New research has shown that early testing for blood clots in patients who had received the AstraZeneca/Oxford vaccine led to them being treated successfully, highlighting the need for heightened awareness of the risk among doctors.

The work, led by researchers from RCSI University of Medicine and Health Sciences and the National Coagulation Centre at St James’s Hospital, is published in the British Journal of Haematology.

Unusual blood clots with low blood platelets have been recognised as a very rare complication of the AstraZeneca vaccine. However, with increased awareness, patients may not have all of these symptoms when they initially present to medical services. 

The researchers highlighted four patients who had clotting complications induced by the vaccine (Vaccine Induced Thrombotic Thrombocytopenia, VITT). Based on the current guidance, each patient could have been classified as a low likelihood for this syndrome when they presented to doctors, but due to the increased awareness and clinical vigilance from the medical teams involved, all were sent for testing early, diagnosed and treated successfully.

“The risk of developing a blood clot from the vaccine is still far lower than the risk of developing clots from Covid-19, but it is imperative that clinicians are vigilant in detecting symptoms among vaccinated patients,” said Dr Michelle Lavin, the lead author of the paper and researcher at the Irish Centre for Vascular Biology and the RCSI School of Pharmacy and Biomolecular Science.

“Our research has shown that current guidelines lack the sensitivity to detect early cases of vaccine-induced clotting, which could risk missing or delaying diagnoses. As our understanding of this novel condition evolves, heightening our clinical awareness can improve outcomes for patients through early testing and treatment.”

This work is part of the Irish COVID-19 Vasculopathy Study (ICVS), supported by a Health Research Board COVID-19 Rapid Response award and also by a philanthropic grant from the 3M Foundation to RCSI University of Medicine and Health Sciences in support of COVID-19 research. The work was carried out in hospitals in both the Republic of Ireland and Northern Ireland.

Previous Post

McCabes Pharmacy introduces new digital prescription service: Easy Script

Next Post

IIOP launches new podcast the resilient pharmacist hosted by Dr. Catriona Bradley

Next Post
IIOP launches new podcast the resilient pharmacist hosted by Dr. Catriona Bradley

IIOP launches new podcast the resilient pharmacist hosted by Dr. Catriona Bradley

Leave a Reply

Your email address will not be published. Required fields are marked *

Sleep, Self-Care & the Pharmacist: The Restorative Role of Routine and Magnesium

Sleep, Self-Care & the Pharmacist: The Restorative Role of Routine and Magnesium

13 June 2025
Role of Pharmacists in Managing Striae: From Prevention to Therapeutics

Role of Pharmacists in Managing Striae: From Prevention to Therapeutics

13 June 2025
Free HRT for Women in Ireland: A Landmark Moment in Menopause Care

Free HRT for Women in Ireland: A Landmark Moment in Menopause Care

12 June 2025

RECOMMENDED NEWS

Keeping an ‘Eye’ on the Pharmacy OTC Market

Keeping an ‘Eye’ on the Pharmacy OTC Market

2 years ago
As the summer winds down and the buzz of the back-to-school season picks up, young people and their parents are gearing up for the year ahead with new skincare routines and fresh starts.

My First Skincare Routine: Preparing Young Skin for the School Year Ahead

12 months ago

May is Melanoma Awareness Month

5 years ago

How To Stay Calm and Protect your Mental Health: A Psychological Toolkit

5 years ago
Tweets by Irish_PharmNews

Quick links

  • About
  • Advertise
  • Careers
  • Contact us

Follow us on social media:

Other info

  • Contact us
  • Register for Digital Magazines
  • Privacy Policy
  • About
  • Advertise
  • Careers
  • Contact us

© 2024 IPN

No Result
View All Result
  • News
  • Learning
  • Other
    • Conferencing
    • Developments
    • Product News
    • Profiles
    • Research
  • Digital Magazines (IPN Online Issues Older Issue Tabs)
  • Awards

© 2024 IPN

  • Login

    Forgot password? | Register

    Register

    Registration confirmation will be emailed to you.

    Login | Forgot password?

    Reset Password

    Please enter your username or email address. You will receive a link to create a new password via email.

    Login

Login

Register

Forgotten Password?

Register | Lost your password?
| Back to Login